From the Department of Dermatology, Faculty of Medicine, Zonguldak Bülent Ecevit University.
Department of Dermatology, Koç University School of Medicine, Istanbul.
Dermatitis. 2021;32(6):397-405. doi: 10.1097/DER.0000000000000631.
Patch testing with the European Baseline Series (EBS) is an essential diagnostic tool for the assessment of allergic contact dermatitis.
The aims of the study were to describe the most common contact allergens identified with patch testing in Turkey and to establish the distribution of contact allergens among different regions in Turkey.
Twelve centers consisting of tertiary health care institutions were included in the study. A total of 1169 patients were patch tested with the EBS from 2015 to 2017.
A total of 596 patients (51.0%) had 1 or more positive patch test reactions to the EBS. A total of 30.2% (n = 353) of those tested had clinical relevance. Contact sensitivity was more common in young patients. The most common 10 allergens were nickel sulfate (20.4%), followed by textile dye mix (8.6%), cobalt chloride (8.3%), potassium dichromate (8.0%), p-phenylenediamine base (4.5%), balsam of Peru (4.3%), methylchloroisothiazolinone/methylisothiazolinone (3.8%), thiuram mix (3.6%), fragrance mix I (3.0%), and methylisothiazolinone (2.9%).
This study provides a comprehensive profile of patch test results with the EBS in Turkey. An ongoing decrease in contact allergy to methylchloroisothiazolinone/methylisothiazolinone and methylisothiazolinone was observed. Textile dye mix and p-phenylenediamine are beginning to pose a new risk in Turkey.
斑贴试验用欧洲基础系列(EBS)是评估过敏性接触性皮炎的重要诊断工具。
本研究旨在描述在土耳其进行斑贴试验时最常见的接触过敏原,并确定土耳其不同地区接触过敏原的分布情况。
本研究纳入了 12 个由三级医疗机构组成的中心。共有 1169 名患者在 2015 年至 2017 年间接受了 EBS 斑贴试验。
共有 596 名患者(51.0%)对 EBS 有 1 种或多种阳性斑贴试验反应。其中 30.2%(n=353)具有临床相关性。接触敏感性在年轻患者中更为常见。最常见的 10 种过敏原是硫酸镍(20.4%),其次是纺织染料混合物(8.6%)、氯化钴(8.3%)、重铬酸钾(8.0%)、对苯二胺基(4.5%)、秘鲁香脂(4.3%)、甲基氯异噻唑啉酮/甲基异噻唑啉酮(3.8%)、噻二唑混合剂(3.6%)、香精混合物 I(3.0%)和甲基异噻唑啉酮(2.9%)。
本研究提供了土耳其 EBS 斑贴试验结果的综合概况。我们观察到对甲基氯异噻唑啉酮/甲基异噻唑啉酮和甲基异噻唑啉酮的接触过敏呈持续下降趋势。纺织染料混合物和对苯二胺基开始在土耳其构成新的风险。